Treatment of catastrophic antiphospholipid syndrome to pregnant woman

A case report

https://doi.org/10.53730/ijhs.v6n1.4524

Authors

  • Nataliya Tytarenko National Pirogov Mem?rial Medical University, Vinnytsia, Ukraine
  • Inna Kukuruza National Pirogov Mem?rial Medical University, Vinnytsia, Ukraine
  • Olga Zasadn?uk National Pirogov Mem?rial Medical University, Vinnytsia, Ukraine
  • Andrii Vozniuk National Pirogov Mem?rial Medical University, Vinnytsia, Ukraine
  • Andriy Kostyuchenko National Pirogov Mem?rial Medical University, Vinnytsia, Ukraine

Keywords:

catastrophic antiphospholipid, diagnose, fetal, postpartum, pregnancy, syndrome

Abstract

The research aimed to study and analyze the life-threatening complication of antiphospholipid syndrome by acute thrombotic microangiopathy, which can lead to multiorgan damage. The progression of catastrophic antiphospholipid syndrome during pregnancy creates a lot of problems in diagnostic due to its extended clinical manifestations and coincidence with additional obstetric intricacies and microangiopathic diseases. Early diagnosis and aggressive treatment (anticoagulants, glucocorticoids, and plasma metabolism (or intravenous immunoglobulins) remain key factors for favorable.  In cases of refractory CAPS, cyclophosphamide or monoclonal antibodies (rituximab, eculizumab) should be considered.

Downloads

Download data is not yet available.

References

Asherson, R. A. (1992). The catastrophic antiphospholipid syndrome. J Rheumatol, 19, 508-512.

Asherson, R. A., Cervera, R., De Groot, P. G., Erkan, D., Boffa, M. C., Piette, J. C., ... & Catastrophic Antiphospholipid Syndrome Registry Project Group. (2003). Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus, 12(7), 530-534.

Berman, H., Rodríguez-Pintó, I., Cervera, R., Morel, N., Costedoat-Chalumeau, N., Erkan, D., ... & Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies. (2013). Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmunity Reviews, 12(11), 1085-1090. https://doi.org/10.1016/j.autrev.2013.05.004

Bucciarelli, S., Cervera, R., Espinosa, G., Gómez-Puerta, J. A., Ramos-Casals, M., & Font, J. (2006). Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmunity Reviews, 6(2), 72-75.

Bucciarelli, S., Cervera, R., Espinosa, G., Gómez-Puerta, J. A., Ramos-Casals, M., & Font, J. (2006). Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors. Autoimmunity Reviews, 6(2), 72-75. https://doi.org/10.1016/j.autrev.2006.06.007

Carmi, O., Berla, M., Shoenfeld, Y., & Levy, Y. (2017). Diagnosis and management of catastrophic antiphospholipid syndrome. Expert review of hematology, 10(4), 365-374.

Chiou, R. K., Anderson, J. C., Wobig, R. K., Rosinsky, D. E., Matamoros Jr, A., Chen, W. S., & Taylor, R. J. (1997). Color Doppler ultrasound criteria to diagnose varicoceles: correlation of a new scoring system with physical examination. Urology, 50(6), 953-956. https://doi.org/10.1016/S0090-4295(97)00452-4

El-Said, K., Syamsuddin, S., Idris, I., Limoa, E., Pelupessy, N., & Syam, A. (2020). The effectiveness of prenatal gentle yoga on the recovery of depression level in primigravid and multigravid pregnant women. International Journal of Health & Medical Sciences, 3(1), 92-97.

Espinosa, G., Berman, H., & Cervera, R. (2011). Management of refractory cases of catastrophic antiphospholipid syndrome. Autoimmunity reviews, 10(11), 664-668. https://doi.org/10.1016/j.autrev.2011.04.031

Espinosa, G., Rodríguez-Pintó, I., & Cervera, R. (2017). Catastrophic antiphospholipid syndrome: an update. Panminerva Medica, 59(3), 254-268.

Gibson, P. S., Powrie, R., & Star, J. (2001). Herbal and alternative medicine use during pregnancy: a cross-sectional survey. Obstetrics & Gynecology, 97(4), S44-S45. https://doi.org/10.1016/S0029-7844(01)01250-9

Gómez-Puerta, J. A., Cervera, R., Espinosa, G., Asherson, R. A., García-Carrasco, M., da Costa, I. P., ... & Font, J. (2007). Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Annals of the rheumatic diseases, 66(6), 740-746.

Gómez-Puerta, J. A., Espinosa, G., & Cervera, R. (2013). Catastrophic antiphospholipid syndrome: diagnosis and management in pregnancy. Clinics in Laboratory Medicine, 33(2), 391-400.

Hakman, E., & Mikhael, S. (2018). Clinical report of probable catastrophic antiphospholipid syndrome in pregnancy. Case Reports in Obstetrics and Gynecology, 2018.

James, A. H., Tapson, V. F., & Goldhaber, S. Z. (2005). Thrombosis during pregnancy and the postpartum period. American journal of obstetrics and gynecology, 193(1), 216-219. https://doi.org/10.1016/j.ajog.2004.11.037

Kazzaz, N. M., McCune, W. J., & Knight, J. S. (2016). Treatment of catastrophic antiphospholipid syndrome. Current opinion in rheumatology, 28(3), 218.

Liston, R., Sawchuck, D., Young, D., Brassard, N., Campbell, K., Davies, G., ... & Scrivener, J. (2007). Fetal health surveillance: antepartum and intrapartum consensus guideline. Journal of Obstetrics and Gynaecology Canada, 29(9), S3-S4. https://doi.org/10.1016/S1701-2163(16)32615-9

Primadewi, K., & Diwyami, N. P. (2021). Correlation of knowledge and family support to compliance with iron (fe) tablet consumption for pregnant women in preventing anemia: new normal COVID-19 era in working area of health centers south kuta. International Journal of Health Sciences, 5(2), 189-201. https://doi.org/10.29332/ijhs.v5n2.1405

Sammaritano, L. R. (2020). Antiphospholipid syndrome. Best Practice & Research Clinical Rheumatology, 34(1), 101463. https://doi.org/10.1016/j.berh.2019.101463

Santi, L. K. S., Sudewi, A. A. R., Duarsa, D. P., & Lesmana, C. B. J. (2021). The effect of pregnancy massage on level of depression, anxiety and stress in pregnant women. International Journal of Health & Medical Sciences, 4(2), 220-225.

Sène, D., Piette, J. C., & Cacoub, P. (2009). Anticorps antiphospholipide, syndrome des anticorps antiphospholipides et infections virales. La Revue de médecine interne, 30(2), 135-141. https://doi.org/10.1016/j.revmed.2008.05.020

Silver, R. M. (2018). Catastrophic antiphospholipid syndrome and pregnancy. In Seminars in perinatology (Vol. 42, No. 1, pp. 26-32). WB Saunders. https://doi.org/10.1053/j.semperi.2017.11.006

Tibballs, J., & Russell, P. (2009). Reliability of pulse palpation by healthcare personnel to diagnose paediatric cardiac arrest. Resuscitation, 80(1), 61-64. https://doi.org/10.1016/j.resuscitation.2008.10.002

Wang, J. Z., Beroukhim, K., Chen, Y. C., Tartar, D., Fung, M., & Brassard, A. (2019). Tumid lupus erythematosus–like pseudovasculitic lesions in catastrophic antiphospholipid syndrome. JAAD Case Reports, 5(2), 198.

Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202

Published

24-02-2022

How to Cite

Tytarenko, N., Kukuruza, I., Zasadn?uk, O., Vozniuk, A., & Kostyuchenko, A. (2022). Treatment of catastrophic antiphospholipid syndrome to pregnant woman: A case report. International Journal of Health Sciences, 6(1), 378–387. https://doi.org/10.53730/ijhs.v6n1.4524

Issue

Section

Peer Review Articles